Awarding ceremonies to be held today, June 9, 2026, at the 17th Annual IMWG Summit in Stockholm, SwedenSTOCKHOLM, June 09,...
Discussion explores challenges of immunologically “cold” tumors and the potential for scalable engineered cell therapies to expand patient access in...
Approval paves the way for CTA313 clinical study in the United States for patients with systemic lupus erythematosus, progressive multiple...
BURLINGTON, Mass., June 09, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine...
Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response...
First Midwest-based account reflects continued execution of the Company's Full Market Release strategy and expansion into additional U.S. territoriesHINGHAM, Mass.,...
AI-based platform, ‘Ask Oscar™’, to accelerate adoption of ENvue's Navigation Platform and enable clinicians to train independently and reduce implementation...
MyGenome Joins a Limited Number of Southeast Asian Laboratories Delivering WGS Under Internationally Recognized Clinical Standards, Strengthening its Position in...
Commercial Launch Planned for Mid-July; 5,000+ Healthcare Facilities Reached Through GPO Agreements, Covering ~60% of Institutional GPO Market U.S. naloxone...
Selection by both the NIA ITP and ARPA-H PROSPR programs highlights growing recognition of LNS8801’s potential to promote healthy agingHADDONFIELD,...
COPD study initiation expands WIN378 development into a second major respiratory diseaseWIN378 is currently being evaluated in the Phase 2/3...
CHICAGO, June 09, 2026 (GLOBE NEWSWIRE) -- R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced...
Product rendering Isupartob sodium - 3 vials Geleen, June 9, 2026 Matisse Pharmaceuticals B.V., a clinical stage company developing a...
Priority review recognizes the serious nature of epidermolysis bullosa (EB) and the urgent need for continued evaluation of potential treatment...
The MUHC Foundation’s Le Bal Rouge Gala raises $2,223,306 million to accelerate discovery in health care at the MUHC’s Glen...
AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology...
Company Positions Platform to Capture High-Value Regional Travel Demand and Build Brand Exposure during Largest Global Sporting Event Northeast Corridor...
ROCKAWAY, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced...
SOUTH SAN FRANCISCO, Calif., June 09, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT), a clinical-stage biotechnology company developing a...
Study Comparing Intranasal Powder Formulation of Ondansetron Demonstrates Comparable Pharmacokinetic Profile to Intravenous Ondansetron in Animal Study; Program to Advance to...